The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study

BACKGROUND: The benefit of tocilizumab on mortality and time to recovery in people with severe COVID pneumonia may depend on appropriate timing. The objective was to estimate the impact of tocilizumab administration on switching respiratory support states, mortality and time to recovery. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Milic, Jovana, Banchelli, Federico, Meschiari, Marianna, Franceschini, Erica, Ciusa, Giacomo, Gozzi, Licia, Volpi, Sara, Faltoni, Matteo, Franceschi, Giacomo, Iadisernia, Vittorio, Yaacoub, Dina, Dolci, Giovanni, Bacca, Erica, Rogati, Carlotta, Tutone, Marco, Burastero, Giulia, Raimondi, Alessandro, Menozzi, Marianna, Cuomo, Gianluca, Corradi, Luca, Orlando, Gabriella, Santoro, Antonella, Digaetano, Margherita, Puzzolante, Cinzia, Carli, Federica, Bedini, Andrea, Busani, Stefano, Girardis, Massimo, Cossarizza, Andrea, Miglio, Rossella, Mussini, Cristina, Guaraldi, Giovanni, D’Amico, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360516/
https://www.ncbi.nlm.nih.gov/pubmed/34383784
http://dx.doi.org/10.1371/journal.pone.0251378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360516/
https://www.ncbi.nlm.nih.gov/pubmed/34383784
http://dx.doi.org/10.1371/journal.pone.0251378

Ejemplares similares